Skip to content

Siddha treatment for Joint pain

A pilot study to evaluate the therapeutic efficacy of Siddha herbo mineral formulations Chandamarutha Chenduram (Internal) and Poonaga thylam (External) in the treatment of "Uthiravatha suronitham" (Rheumatoid arthritis)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/006125
Enrollment
40
Registered
2011-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Uthira vatha suronitham (Rheumatoid arthritis)

Interventions

Intervention1: Chandamarutha Chenduram: 65 mg internal(twice a day) with palm jaggery for 7 days followed by a break of 5 days and repeated this prescription till the course of 48 days ends. Every fir
s milk Intervention2: Poonaga Thylam: External Medicine, 50 ml (twice a day) applied externally over the affected part. Dietary restriction: Diet free of salt and tamarind should be followed througho

Sponsors

National Institute of Siddha Chennai Tamil Nadu India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age: 15-60 years, Sex: Both male and female Patients having the symptoms of arthritis of three or more joints, symmetrical joint involvement, swelling especially in inter phalangeal joints, morning stiffness of joints, low grade fever, serum rheumatoid factor both positive and negative, anorexia & mental stress Patients who are willing to give radiological investigation and provide blood for lab investigation Patient willing to sign informed consent stating that he/she will conscientiously stick to the treatment during 48 days but can opt out of the trial of his/her own conscious discretion

Exclusion criteria

Exclusion criteria: Cardiac disease Hypertension Diabetes mellitus Use of narcotic drugs Pregnancy and lactation History of trauma Tuberculosis Bronchial asthma Any other serious illness

Design outcomes

Primary

MeasureTime frame
Universal Pain Assessment Scale (0-10)Timepoint: before and after treatment

Secondary

MeasureTime frame
Hb & ESR variationTimepoint: Before and after;RA factor & CRP VariationTimepoint: Before and After treatment;Reduction in other clinical symptomsTimepoint: Before and after treatment;Restricted movement assessment scaleTimepoint: before and after

Countries

India

Contacts

Public ContactDrNalini Sofia

National Institute of Siddha

dr.kmvm@gmail.com044-22381314

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026